Comparing the outcomes of noninferiority (NI) and superiority phase III trials.

被引：0
|
作者：
Saad, Everardo D.
Buyse, Marc E.
机构：
[1] Dendrix Res, Sao Paulo, Brazil
[2] Int Inst Drug Dev, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13055
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Lack of pre-planned financial outcomes evaluation in phase 3 cancer trials.
    Noticewala, Sonal S.
    Jaoude, Joseph Abi
    Kouzy, Ramez
    Patel, Roshal
    Chino, Fumiko
    Smith, Grace L.
    Fuller, Clifton Dave
    Thomas, Charles R.
    Koong, Albert C.
    Das, Prajnan
    Taniguchi, Cullen M.
    Ludmir, Ethan B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Clinical outcomes and survival of advanced renal cancer patients in Phase I clinical trials.
    Malik, Laeeq
    Parsons, Helen
    Mahalingam, Devalingam
    Ehler, Benjamin
    Goros, Martin
    Brenner, Andrew
    Sarantopoulos, John
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [43] Outcomes of patients ≥ 65 yrs with advanced cancer treated on phase I clinical trials.
    Subbiah, Ishwaria Mohan
    Wheler, Jennifer J.
    Hess, Kenneth R.
    Hong, David S.
    Fu, Siqing
    Wolff, Robert A.
    Kurzrock, Razelle
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials.
    Andre, Fabrice
    Su, Fei
    Solovieff, Nadia
    Arteaga, Carlos L.
    Hortobagyi, Gabriel N.
    Chia, Stephen K. L.
    Neven, Patrick
    Bardia, Aditya
    Tripathy, Debu
    Lu, Yen-Shen
    Wang, Yingbo
    Rodriguez-Lorenc, Karen
    Taran, Tetiana
    Babbar, Naveen
    Slamon, Dennis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Repeated confidence intervals in self-designing clinical trials and switching between noninferiority and superiority
    Hartung, Joachim
    Knapp, Guido
    BIOMETRICAL JOURNAL, 2006, 48 (04) : 697 - 709
  • [46] Conditional Type I Error Rate for Superiority Test Conditioned on Establishment of Noninferiority in Clinical Trials
    Yuan, Jiacheng
    Tong, Tiejun
    Ng, Tie-Hua
    DRUG INFORMATION JOURNAL, 2011, 45 (03): : 331 - 336
  • [47] Conditional Type I Error Rate for Superiority Test Conditioned on Establishment of Noninferiority in Clinical Trials
    Jiacheng Yuan
    Tiejun Tong
    Tie-Hua Ng
    Drug information journal : DIJ / Drug Information Association, 2011, 45 : 331 - 336
  • [48] The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology
    Jatoi, Ismail
    Gail, Mitchell H.
    JAMA ONCOLOGY, 2020, 6 (03) : 420 - 424
  • [49] Abciximab improves outcomes in patients of all ages: Pooled analysis of 4 phase 3 trials.
    Effron, MB
    Booth, J
    Balog, C
    Cabot, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 69I - 69I
  • [50] Comparing the Response Rates for Superiority, Noninferiority and Equivalence Testing with Multiple-to-One Matched Binary Data
    Tsong, Yi
    Yuan, Mengdie
    Dong, Xiaoyu
    Wu, Yu-te
    Shen, Meiyu
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (01) : 98 - 109
12345